H. Lane

Nature Reviews. Cancer · 2000–2009

A researcher in the Science corpus: 6 papers; trusts 0 researchers and is trusted by 14 researchers here, as inferred from the citation graph.

Whom H. Lane trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Thomas Holbro

Who trusts H. Lane overall

  1. J. Baselga
  2. S. Bhattacharyya
  3. N. Hynes
  4. J. Mendelsohn
  5. Thomas Holbro
  6. M. Scaltriti
  7. D. Longley

Papers from H. Lane's perspective

Ordered by how strongly the researchers H. Lane trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth. (Cancer Cell)
  2. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets (Nature Medicine)
  3. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab (Nature)
  4. The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. (Molecules and Cells)
  5. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. (Cell)
  6. Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification (Science)
  7. EGF receptor ligands. (Experimental Cell Research)
  8. ErbB receptors: directing key signaling networks throughout life. (Annual Review of Pharmacology and Toxicology)
  9. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. (Molecules and Cells)
  10. Targeting HIF-1 for cancer therapy (Nature Reviews. Cancer)

Their papers